Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir

AIM: To examine the efficacy of telbivudine (LdT) + adefovir (ADV) vs continuation of lamivudine (LAM) + ADV in patients with LAM-resistant chronic hepatitis B (CHB) who show a suboptimal response to LAM + ADV. METHODS: This was a randomized, active-control, open-label, single-center, parallel trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, Hana, Park, Jun Yong, Kim, Seung Up, Kim, Do Young, Han, Kwang-Hyub, Chon, Chae Yoon, Ahn, Sang Hoon
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837266/
https://ncbi.nlm.nih.gov/pubmed/24431895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i43.7671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados